Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2015

01-01-2015 | Original Contributions

Roux-en-Y Gastric Bypass Reduces Lipid Overaccumulation in Liver by Upregulating Hepatic Autophagy in Obese Diabetic Rats

Authors: Bing He, Letong Liu, Chong Yu, Yong Wang, Ping Han

Published in: Obesity Surgery | Issue 1/2015

Login to get access

Abstract

Background

The decrease in lipotoxicity is one of the crucial mechanisms by which Roux-en-Y gastric bypass (RYGB) improves insulin sensitivity. Little work, however, has been performed to elucidate the exact mechanism of RYGB reducing hepatic lipid overaccumulation in response to heavy lipid and glucose challenge. Here, we explored the effects of RYGB on hepatic autophagy in obese diabetic rats.

Methods

Sprague–Dawley rats were divided into five groups: diabetic RYGB, diabetic RYGB sham, diabetic food restriction (FR), diabetic rats, and non-diabetic controls (n = 12/group). At 4-week post-operation, genetic and protein expressions of autophagy markers including Atg7 and Beclin 1 and the conversion of LC3 were examined with quantitative RT-PCR and Western blotting. Plasma glucagon-like peptide-1 (GLP-1) and triglyceride and total cholesterol levels in liver tissue were tested.

Results

In both genetic and protein levels, we observed a significant upregulated autophagy in liver at 4 weeks after RYGB. Restored autophagy in liver played a key role in reducing the hepatic lipid burden in obese diabetic rats. The marked increase of autophagy in liver after RYGB correlated well with the plasma GLP-1 level.

Conclusions

Our data demonstrate that RYGB significantly upregulated hepatic autophagy. We suggest that the effects of RYGB on autophagy in liver may be due to the increased GLP-1 level after surgery. Moreover, the activated autophagy in liver might play a key role in reducing the hepatic lipid overaccumulation after RYGB.
Literature
1.
Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systemic analysis of health examination surveys and epidemiological studies with 370 county-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.PubMedCrossRef
2.
Puterbaugh JS. The emperor’s tailors: the failure of the medical weight loss paradigm and its causal role in the obesity of America. Diabetes Obes Metab. 2009;11(6):557–70.PubMedCrossRef
3.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.PubMedCrossRef
4.
Ashrafian H, Athanasiou T, Li JV, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev. 2011;12(5):e257–72.PubMedCrossRef
5.
He B, Piao D, Yu C, et al. Amelioration in hepatic insulin sensitivity by reduced hepatic lipid accumulation at short-term after Roux-en-Y gastric bypass surgery in type 2 diabetic rats. Obes Surg. 2013;23(12):2033–41.PubMedCrossRef
6.
He B, Chen L, Yu C, et al. Roux-en-Y gastric bypass increases hepatic and peripheral insulin sensitivity in rats with type 2 diabetes mellitus. Surg Obes Relat Dis. 2013;1550–7289(13):00324–9.
7.
Noboru M, Beth L, Ana M. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–75.CrossRef
8.
Finn PF, Dice JF. Proteolytic and lipolytic responses to starvation. Nutrition. 2006;22(7–8):830–44.PubMedCrossRef
9.
Iwata J, Ezaki J, Komatsu M, et al. Excess peroxisomes are degraded by autophagic machinery in mammals. J Biol Chem. 2006;281(7):4035–41.PubMedCrossRef
10.
11.
12.
Benjamin JL, Sumpter Jr R, Levine B, et al. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. Cell Host Microbe. 2013;13(6):723–34.PubMedCentralPubMedCrossRef
13.
Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313–20.PubMedCrossRef
14.
Meirelles K, Ahmed T, Culnan DM, et al. Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg. 2009;249(2):277–85.PubMedCentralPubMedCrossRef
15.
Lam TK, Yoshii H, Haber CA, et al. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Endocrinol Metab. 2002;283(4):E682–91.PubMed
16.
Shearer J, Duggan G, Weljie A, et al. Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6 J mouse. Diabetes Obes Metab. 2008;10(10):950–8.PubMedCrossRef
17.
Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol. 2001;116(1):63–8.PubMed
18.
Ling Y, Ping L, Suneng F, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467–78.CrossRef
19.
Furuhashi M, Tuncman G, Gorgun CZ, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959–65.PubMedCentralPubMedCrossRef
20.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–70.PubMedCrossRef
21.
Shah M, Law JH, Micheletto F, et al. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014;63(2):483–93.PubMedCrossRef
22.
Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol. 2006;7(5):373–8.CrossRef
23.
24.
Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19(21):5720–8.PubMedCentralPubMedCrossRef
25.
Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007;9(10):1102–9.PubMedCrossRef
26.
Colucci RA. Bariatric surgery in patients with type 2 diabetes: a viable option. Postgrad Med. 2011;123(1):24–33.PubMedCrossRef
27.
Singh R, Xiang Y, Wang Y, et al. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest. 2009;119(11):3329–39.PubMedCentralPubMed
28.
Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007;10(2):142–8.PubMedCrossRef
29.
30.
31.
Aijälä M, Malo E, Ukkola O, et al. Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. Genes Nutr. 2013;8(6):623–35.PubMedCentralPubMedCrossRef
32.
Habegger KM, Heppner KM, Amburgy SE, et al. GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes. 2014;63(2):505–13.PubMedCrossRef
33.
Bhat VK, Kerr BD, Vasu S, et al. A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice. Diabetologia. 2013;56(6):1417–24.PubMedCrossRef
34.
Jing Yin J, Bo Li Y, Ming Cao M, et al. Liraglutide improves the survival of INS-1 cells by promoting macroautophagy. Int J Endocrinol Metab. 2013;11(3):184–90.PubMedCentralPubMedCrossRef
35.
Sharma S, Mells JE, Fu PP, et al. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS One. 2011;6(9):e25269.PubMedCentralPubMedCrossRef
Metadata
Title
Roux-en-Y Gastric Bypass Reduces Lipid Overaccumulation in Liver by Upregulating Hepatic Autophagy in Obese Diabetic Rats
Authors
Bing He
Letong Liu
Chong Yu
Yong Wang
Ping Han
Publication date
01-01-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1342-7

Other articles of this Issue 1/2015

Obesity Surgery 1/2015 Go to the issue

Original Contributions

Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up

Video Submission

Laparoscopic Gastric Sleeve, Subtotal Antrectomy and Omentoplasty

Erratum

Erratum to: Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-En-Y Gastric Bypass for Morbid Obesity and Related Comorbidities: A Meta-Analysis of 21 Studies

New Concept

Early Experience with Customized, Meal-Triggered Gastric Electrical Stimulation in Obese Patients

Brief Communication

The Effect of Insurance Status on Pre- and Post-operative Bariatric Surgery Outcomes

Letter to the Editor

Standardizing or Tailoring Bariatric Surgery